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The genetic material controls life activities of the cell through
regulating the synthesis of proteins which directly mediate
these activities. Regulatory genes, in addition, control the tran-
scription of many classes of small RNAs that have fundamen-
tal roles in direct and feed-back regulation of most aspects of
the genetic material [1].
Mutations cause structural alterations of the genetic mate-
rial. Depending on the site, nature, magnitude and effects of
the mutational event as well as on the functions and importance
of the mutated genes, pathogenetic mechanisms that result in
deﬁcient synthesis of gene products, synthesis of defective gene
products or disturbed regulation of cellular activities will lead
to the development of genetic disorders, secondary to the ensu-
ing pathophysiological alterations of cellular functions.
Maintaining the stability, integrity and species-speciﬁc iden-
tity of the genome represents a prerequisite, not only for exe-
cuting cell functions properly, but more fundamentally for
the beginning, continuation and conservation of life. It is the
preservation of the collaborative and integrated intimate rela-
tionship of these three aspects of the genome that represent the
real kernel and true essence of existence of all forms of life.
Many pathogenetic mechanisms that drastically affect genome
stability and genome integrity have been deﬁned. These partic-
ular groups of mutations constitute important detrimental
events that act via different pathways, e.g. defective genetic re-* Tel.: +20 1225874345/33354379.
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http://dx.doi.org/10.1016/j.ejmhg.2012.12.001pair mechanisms or the premature induction of apoptosis,
leading ultimately to the loss of genome stability, integrity
and induction of cell death. On molecular or cellular level,
these mutations might be considered as life-ending mutations.
These mutations might also act in a different way through
the total loss of reproductive ﬁtness and the disappearance
of individual genomes from the gene pool of certain species [2].
The spectrum of pathogenetic mechanisms and the resulting
pathophysiological disturbances that underlie the development
of genetic disorders is quite wide in view of the complexity of
the structural organization of the genome and the strict func-
tional specialization that characterizes each of its components.
Additionally, the obscure nature and unclear functions of many
components of the genetic material, undoubtedly, conceal
many, still unknown, pathogenetic mechanisms and hinder
proper understanding of their exact pathways. It is hoped that
the ﬁnal completion of the human genome project might dis-
close the exact and complete structural organization of the hu-
man genome. However, a parallel human genome function
project aiming at deﬁning the complete functional spectrum
of the genome seems to be an indispensable and imperative task
in order to ﬁnalize the knowledge of our genetic material [3].
Currently deﬁned pathogenetic mechanisms and patho-
physiological alterations implicated in the pathogenesis of ge-
netic disorders include the following:
1. Loss/damage/duplication/inactivation of nuclear genes
2. Mutation of mitochondrial genes (mitDNA)
3. Deﬁcient/defective DNA replication/repair
4. Triplet repeat expansion disorders
5. Loss/acquisition/damage of chromosomes
6. Deﬁcient transcription of mRNA
7. Transcription of defective mRNA
8. Deﬁcient/defective post-transcription mRNA repairier B.V. All rights reserved.
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mRNA
10. Deﬁcient translation of proteins
11. Translation of defective proteins
12. Deﬁcient/defective post-translation modiﬁcation of
proteins
13. Deﬁcient/defective post-translation repair of misfolded
proteins
14. Deﬁcient/defective post-translation targeting and traf-
ﬁcking of proteins
15. Deﬁcient/defective regulation of cell growth
16. Deﬁcient/defective regulation of cell division
17. Deﬁcient/defective regulation of cell differentiation
18. Deﬁcient/defective regulation of cell migration
19. Deﬁcient/defective regulation of intercellular contact
and cell movement
20. Deﬁcient/defective apoptosis/selection repair
21. Deﬁcient/defective regulation of cell architecture and
cytoskeleton: e.g. ciliary dyskinesia disorders (bronchi-
ectasis, dextrocardia and situs-inversus, hydronephrosis,
hydrocephaly, male infertility and repeated abortions),
hereditary spherocytosis, Wiskott-Aldrich syndrome
and neural tube defects.
22. Imprinting disorders: genomic imprinting disorders, e.g.
ovarian teratomas and hydatidiform moles, and genic
imprinting diseases, e.g. Prader-Willi syndrome, Angel-
man syndrome, Silver-Russell syndrome and Beckwith-
Wiedemann syndrome.
23. Deﬁcient/defective regulation of cellular functions:
a. Deﬁcient/defective transport across cell mem-
brane or membranes of cell organelles (transport
defects)Table 1 Anti-mutation mechanisms of the human genome.
Anti-mutation mechanisms of the human genome
Mechanism Types & pathways & com
1. Structural organization of the genome 1. Nuclear genome
2. Mitochondrial genome
2. Structural features of DNA Complementary strand sto
3. Degeneracy of the genetic code Multiple point mutations
4. Nuclear localization of DNA Physical protection of nuc
5. DNA-associated proteins 1. Physical barriers
2. Biochemical buﬀers
3. Deactivating biomolecu
4. Modulation of charge t
5. Limitation of DNA hel
6. Replication proofreading system Prophylactic pathway dur
7. Genetic repair systems A. Nuclear DNA repair
1. Base excision repair
2. Nucleotide excision rep
3. Direct reversal repair
4. Mismatch repair
5. Recombination repair
B. RNA repair/editing sys
Post-transcription repair/e
complex
C. Mitochondrial DNA (m
8. Protein repair systems Correction of post-transla
9. Silencing of transposons by piwiRNA Reduces transposon-induc
10. Antioxidant enzyme systems
11. Apoptosis Prophylactic pathway aga
daughter cells
12. Melatonin Anti-clastogenic, anti-mutb. Deﬁcient/defective transport across cell pores, nuclear
pores or pores of cell organelles (chanellopathies)
c. Deﬁcient/defective secretion of gene products (pro-
tein/enzyme deﬁciency disorders)
d. Deﬁcient/defective excretion of metabolic waste
products (storage disorders)
e. Deﬁcient/defective regulation of intra and inter net-
work reactions and interactions: signal transduction
disorders: e.g. neurodegeneration, diabetes mellitus,
schizophrenia and Noonan syndrome.
f. Deﬁcient/defective positioning of structural proteins
(cell cytoskeleton disorders)
g. Deﬁcient/defective regulation of intracellular
trafﬁcking.
h. Deﬁcient/defective production of cellular energy:
oxidative-phosphorylation disorders.
i. Ubiquitination/proteasome degradation defects: e.g.
Friedreich ataxia, Huntington disease, Parkinson
disease, Alzheimer disease, Angelman syndrome,
motor neurone disease and immunodeﬁciency.
j. Apoptosis defects: e.g. congenital malformations,
autoimmune disorders, cancer and neurodegenera-
tion [4,5].2. Anti-mutation mechanisms of the human genome and human
proteome
The human genome develops, persists and works in a hostile
environment full of existing, and continuously generated,
mutagens. Mutational events induced by external factors,
which include physical, chemical and biological mutagens,ments
res genetic information
might occur without aﬀecting synthesized protein
lear genome
les
ransport
ix distortion
ing DNA replication
air
tem
diting of some mRNA defects via guide RNA (gRNA)/editosome
tDNA) repair
tion protein misfolding/aggregation by chaperones
ed mutations during development
inst spread of mutations of heavily or lethally mutated genomes to
agenic, anti-carcinogenic and anti-oxidant compound.
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rity of the genome as well as on the stability and integrity of the
proteome. Additionally, further and considerable damage of
the structural organization and functional capabilities of both
the genome and the proteome regularly occurs on continuous
and progressive basis due to the continuously generated bur-
den of internal mutagens that result from the diverse metabolic
activities of the exceedingly large number of metabolic net-
works of the cell. Unless a powerful and effective protective
and repair system actively participates in protecting the gen-
ome and proteome of the cell against the deleterious effects
of mutations, and in efﬁcient repair of resulting damage, main-
taining the stability and integrity of both of these bio-systems
that constitute the framework of life activities within the cell
would have been impossible [2].
The human genome is endowed with a spectacular multifac-
eted strong anti-mutation system responsible for maintaining
stability and integrity of the genome and preserving its iden-
tity. It acts by protecting the genome from the detrimental ef-
fects of mutation and by repairing mutation-induced damage.
Obviously, the balance between the pathological effects of
mutation and the ability of the anti-mutation system to coun-
teract and to reduce the consequences of these effects repre-
sents the main factor that determines the likelihood of
having a mutation-induced genetic disease. The human anti-
mutation system comprises both innate mechanisms common
to, and shared by, all individuals, e.g. degeneracy of the genetic
code, and acquired aspects determined by the inherited genetic
background of each human being, e.g. DNA repair system [6].
The human transcriptome, being subjected to the same
mutational events that can affect, alter and damage the
DNA, seems to have efﬁcient anti-mutation mechanisms to
guard against occurrence of errors during RNA transcription
and to correct and repair some post-transcription defects of
mRNA that can cause errors during protein translation. A sep-
arate RNA-proofreading system seems to exist and it probably
acts during transcription by relying on the sequence comple-
mentarity information or database stored within the comple-
mentary silent or non-transcribing strand of DNA.
Depending on the sequence of the active strand to ensure accu-
rate transcription might result in improper transcription if mis-
match errors occur due to, e.g. polymerase dysfunction. This
assumption might, partly, explain the still un-understandable
behavior of gene function which involves, seemingly needless,
indirect and energy consuming mechanisms by transcribing a
complementary mRNA molecule, rather than an identical
mRNA, that has to be decoded again by rRNA and tRNA
in the ribosome during translation [Table 1].Appendix A. Part II: MCQs
A.1. Choose the best answer
1- FISH stands for:
a- ﬂuorescent in situ hybridization
b- ﬁrst induced strand hybrid.
c- F1 insertion segment homolog.
d- ﬂanking insertion sequence hybrid.
e- ﬂuorescent insertion segment hybrid2- Lod score measures:
a- the relatedness of two individuals.
b- the length of genetic distances.
c- how often double crossovers occur.
d- the length of a linkage group.
e- the likelihood of linkage between genes3- Crossing over occurs during:
a- interphase.
b- prophase.
c- metaphase.
d- anaphase.
e- telophase.4- Inheritance of both chromosomes from the same parent
is a condition called:a- displaced duplication
b- uniparental disomy
c- tandem duplication
d- unbalanced polymorphism
e- nondisjunction5- Enzyme assay can be used to identify carriers of:a- Cystic ﬁbrosis
b- Fragile X syndrome
c- Oculocutaneous albinism
d- Tay-sachs disease
e- b-thalssemia6- Maternal serum level of alpha-fetoprotein (AFP) is
lower than average in:
a- Neural tube defects
b- Exomphalos
c- Down syndrome
d- Twin preganancy
e- Spina biﬁda7- The risk for miscarriage associated with amniocentesis is
approximately:a- 1 in 10
b- 1 in 50
c- 1 in 100–200
d- 1 in 1000
e- 1 in 100008- Which of the following karyotypes is NOT compatible
with survival to birth:
a- 47, XY, +13
b- 47, XX, +18
c- 47, XY, +21
d- 47, XX, +16
e- 48, XXY9- The DiGeorge/Shprintzen syndrome is caused by a dele-
tion in:
a- chromosome 4
b- chromosome 7
c- chromosome 15
d- chromosome 21
e- chromosome 22
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ity syndrome:
a- Poikiloderma of Civatte
b- Ataxia telangectasia
c- Bloom syndrome
d- Fanconi anemia
e- Xeroderma pigmentosum11- Polyploidy refers to:
a- extra copies of a genes adjacent to each other on a
chromosome
b- complete extra sets of haploid genome
c- chromosome which has replicated but not divided
d- multiple ribosomes present on a single mRNA
e- inversion which does not include the centromere12- Choose the correct statement about the genetic code:a- includes 61 codons for amino acids and 3 stop
codons
b- is almost universal; exactly the same in most ge-
netic systems
c- consists of three bases per codon
d- some amino acids are coded by multiple codons
e- all of the above13- X-chromosome inactivation:
a- normally takes place in males but not females:
b- is the cause of the Y chromosome being geneti-
cally inactive
c- the same X chromosome is inactive in all of the
cells of a female
d- occurs in fruit ﬂies but not in mammals
e- results in genetically turning off one of the two X
chromosomes in female mammals14- Chromosome duplication denotes:
a- reciprocal exchange between non-homologous
chromosomes.b- loss of genes in part of a chromosome
c- extra copies of genes on part of a chromosome
d- a reversal of order of genes on a chromosome
e- extra sets of chromosomes in an organism15- Male to male transmission is a key feature of:
a- Autosomal dominant inheritance
b- Autosomal recessive inheritance
c- X-linked dominant inheritance
d- X-linked recessive inheritance
e- None of the aboveAnswers:
1 A 6 C 11 B
2 E 7 C 12 E
3 B 8 D 13 E
4 B 9 E 14 E
5 D 10 A 15 AReferences
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